Providing an Evidence Base for Tissue Sampling and Culture Interpretation in Suspected Fracture-Related Infection
Overview
Orthopedics
Affiliations
Background: The recent consensus definition for the diagnosis of fracture-related infection (FRI) includes the identification of indistinguishable microorganisms in at least 2 surgical deep-tissue specimens as a confirmatory criterion. However, this cut-off, and the total number of specimens from a patient with suspected FRI that should be sent for microbiological testing, have not been validated. We endeavored to estimate the accuracy of different numbers of specimens and diagnostic cut-offs for microbiological testing of deep-tissue specimens in patients undergoing surgical treatment for possible FRI.
Methods: A total of 513 surgical procedures in 385 patients with suspected FRI were included. A minimum of 2 surgical deep-tissue specimens were submitted for microbiological testing; 5 or more specimens were analyzed in 345 procedures (67%). FRI was defined by the presence of any confirmatory criteria other than microbiology. Resampling was utilized to model the sensitivity and specificity of diagnostic cut-offs for the number of surgical specimens yielding indistinguishable microorganisms and for the total number of specimens. The likelihood of detecting all clinically relevant microorganisms was also assessed.
Results: A diagnostic cut-off of at least 2 of 5 specimens with indistinguishable microorganisms identified by culture was 68% sensitive (95% confidence interval [CI], 62% to 74%) and 87% specific (95% CI, 81% to 94%) for the diagnosis of FRI. Two out of 3 specimens were 60% sensitive (95% CI, 55% to 66%) and 92% specific (95% CI, 88% to 96%). Submitting only 3 deep-tissue specimens risked missing clinically relevant microorganisms in at least 1 in 10 cases.
Conclusions: The present study was the first to validate microbiological criteria for the diagnosis of FRI, supporting the current confirmatory diagnostic criteria for FRI. Analysis of at least 5 deep-tissue specimens in patients with possible FRI is recommended.
Level Of Evidence: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Sukpanichyingyong S, Sae-Jung S, Stubbs D, Luengpailin S Sci Rep. 2025; 15(1):7732.
PMID: 40044740 PMC: 11882985. DOI: 10.1038/s41598-025-91990-1.
Unsworth A, Young B, Scarborough M, McNally M Antibiotics (Basel). 2025; 13(12.
PMID: 39766515 PMC: 11672718. DOI: 10.3390/antibiotics13121125.
Incidence and Risk Factors of Infection After Fracture Fixation: A Multicenter Cohort Study.
Wang B, Zhang J, Han W, Tang X, Tian F Orthop Surg. 2024; 17(1):151-162.
PMID: 39501777 PMC: 11735356. DOI: 10.1111/os.14278.
Velasquez A, Klautau G, Kurihara M, Santos I, Campos L, Silva M Braz J Microbiol. 2024; 55(4):3591-3601.
PMID: 39466565 PMC: 11711840. DOI: 10.1007/s42770-024-01545-1.
Pediatric calcaneal osteomyelitis: an analysis of literature-reported 128 cases.
Dhagey I, Liu Z, Zhong H, Chen P, Qalalwa M, Martin V BMC Infect Dis. 2024; 24(1):998.
PMID: 39294568 PMC: 11409617. DOI: 10.1186/s12879-024-09887-9.